User:Mr. Ibrahem/Dupilumab

Dupilumab, sold under the brand name Dupixent, is a medication used for eczema (atopic dermatitis), asthma, or nasal polyps. It is used in eczema when topical corticosteroids have not been sufficient. It is given by injection under the skin.

Common side effects include pain at the site of injection, dry eyes, throat pain, trouble sleeping, and red eyes. Other side effects may include allergic reactions, cold sores, and inflammation of the cornea. Safety in pregnancy is unclear. It is a monoclonal antibody that blocks the target receptors of interleukin 4 (IL4) and interleukin 13 (IL13).

Dupilumab was approved for medical use in the United States and Europe in 2017. In the United Kingdom it costs the NHS about £1,300 every 4 weeks as of 2021. In the United States this amount costs about 3,400 USD.